440 filings
Page 8 of 22
6-K
ws2hf qeef2btz4g3e3s
8 Mar 18
This marks Zydus' first branded product launch in the U.S. and Medicure's second cardiovascular drug on the U.S. market
12:00am
6-K
gnc0 ubnzcz4wupb66
1 Feb 18
Current report (foreign)
12:00am
6-K
0u9 ex3y6d
1 Feb 18
Medicure Announces Receipt of Deferred Proceeds from Apicore Sale
12:00am
6-K
9oklys
26 Dec 17
Current report (foreign)
12:00am
6-K
843lmyud
20 Dec 17
Current report (foreign)
12:00am
6-K
e5908vp hx271mypwr
19 Dec 17
Current report (foreign)
12:00am
6-K
zvo45hf mxt1c3gl6trt
22 Nov 17
Current report (foreign)
12:00am
6-K
ems2 lwynx39u3
22 Nov 17
Condensed Consolidated Interim Financial Statements
12:00am
6-K
c264x2g88oncvn8p
17 Nov 17
Medicure Announces Repayment of Outstanding Debt
12:00am
6-K
by6ser
16 Nov 17
Medicure Q3 Results and Conference Call Dates
12:00am
6-K
tgscentipb5w8sm1y
1 Nov 17
Current report (foreign)
12:00am
6-K
ybxu g0f52i
1 Nov 17
Medicure Acquires Exclusive License to Sell and Market PREXXARTAN® in the U.S. from Carmel Biosciences
12:00am
6-K
iwfpyngk
16 Oct 17
Current report (foreign)
12:00am
UPLOAD
llh439ci7smwlzi
12 Oct 17
Letter from SEC
12:00am
6-K
1rh7u gvh08jtxo
3 Oct 17
Medicure Announces Sale of Apicore Business
12:00am
CORRESP
dwd u5rbyqzygh9xmb
22 Sep 17
Correspondence with SEC
12:00am
UPLOAD
4guuh12 2r
8 Sep 17
Letter from SEC
12:00am
6-K
ukcofjb jr
8 Aug 17
Current report (foreign)
12:00am
6-K/A
l4vk70u2b0lgm
8 Aug 17
Condensed Consolidated Interim Financial Statements
12:00am
6-K
atrgsz7f
7 Aug 17
Condensed Consolidated Interim Financial Statements
12:00am